Expansion Opportunity Significant growth underway in Massachusetts with plans to add up to 600 jobs and relocate headquarter operations to Somerville by 2028, presenting a strong opening for partnerships around expanded OCS deployment, service coverage, and local clinical training programs.

International Reach Strategic investment in PAD Aviation to extend the National OCS Program model to major transplant centers across Europe, creating opportunities for European distributors, logistics partnerships, and cross-border organ transport optimization.

Clinical Leadership FDA-approved Organ Care System for lung, heart, and liver transplant indications positions TransMedics as a premium partner for hospitals seeking to expand donor criteria, reduce organ discard, and increase transplant volumes.

Financial Growth Reported revenue in the high hundreds of millions with ongoing cost increases; potential sales angles include breadth of OCS indications, regional service contracts, and expanded training and support packages to maximize utilization.

Innovation & Partnerships Continuous investment in technology stack and clinical support networks (NOP, 24/7 logistics) creates upsell opportunities for enhanced analytics, remote monitoring, and integrated logistics solutions aligned with hospital procurement and supplier diversity programs.